Calithera Biosciences, Inc. Recorded Big Gain
Thu, Aug 29, 2024 at 07:41 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) rocketted at $0.02, a gain of 60%. On Thu, Aug 29, 2024, CALA:NASDAQ touched a New 2-Week High of $0.02. From Thu, Aug 15, 2024, the stock recorded 20.00% Up Days and 0.00% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 130.77%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 60%
- Innovative Eyewear Inc. (LUCY:NASDAQ), 53.78%
- Movella Holdings Inc Com (MVLA:NASDAQ), 49%
- Singularity Future Technology Ltd. (SGLY:NASDAQ), 39.86%
- Raytech Holding Limited (RAY:NASDAQ), 38.67%
- Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT), 34.29%
- ARCA biopharma, Inc. (ABIO:NASDAQ), 32.49%
- Affirm Holdings Inc. (AFRM:NASDAQ), 31.92%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 30.24%